CFAGX
Price
$37.46
Change
+$0.11 (+0.29%)
Updated
Sep 4 closing price
Net Assets
113.98M
PMBJX
Price
$37.33
Change
-$0.41 (-1.09%)
Updated
Sep 4 closing price
Net Assets
22.34B
Interact to see
Advertisement

CFAGX vs PMBJX

CFAGX vs PMBJX Comparison Chart in %
View a ticker or compare two or three
VS
CFAGX vs. PMBJX commentary
Sep 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CFAGX is a Hold and PMBJX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMBJX has more cash in the bank: 22.3B vs. CFAGX (114M). CFAGX pays higher dividends than PMBJX: CFAGX (0.07) vs PMBJX (0.00). CFAGX was incepted earlier than PMBJX: CFAGX (32 years) vs PMBJX (26 years). CFAGX (0.84) is less costly to investors than PMBJX (0.76). CFAGX is a more actively managed with annual turnover of: 74.00 vs. PMBJX (13.70). CFAGX (1000) and PMBJX (1000) have matching initial minimum investment requirements. PMBJX annual gain was more profitable for investors over the last year : -13.87 vs. CFAGX (-21.07). PMBJX return over 5 years is better than : -5.62 vs. CFAGX (-37.24).
CFAGXPMBJXCFAGX / PMBJX
Total Expense Ratio0.840.76111%
Annual Report Gross Expense Ratio0.840.76111%
Fund Existence32 years26 years-
Gain YTD3.692-3.107-119%
Front LoadN/AN/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets114M22.3B1%
Annual Yield % from dividends0.070.00-
Returns for 1 year-21.07-13.87152%
Returns for 3 years-13.0014.64-89%
Returns for 5 years-37.24-5.62663%
Returns for 10 years5.9574.358%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SIDNX16.60N/A
N/A
Hartford Schroders Intl Multi-Cp Val I
HBGHX16.44N/A
N/A
Hartford Healthcare HLS IB
FBTDX183.00N/A
N/A
Franklin Biotechnology Discovery C
OIEQX29.12N/A
N/A
JPMorgan Equity Income R4
VYGLX13.08N/A
N/A
Voya Global Income & Growth I